help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindsay, R. S.
Right arrow Articles by Walker, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindsay, R. S.
Right arrow Articles by Walker, J. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Diabetes and Pregnancy
*High Risk Pregnancy
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 7 3436-3439
Copyright © 2004 by The Endocrine Society

Type 1 Diabetes-Related Antibodies in the Fetal Circulation: Prevalence and Influence on Cord Insulin and Birth Weight in Offspring of Mothers with Type 1 Diabetes

R. S. Lindsay, A.-G. Ziegler, B. A. Hamilton, A. A. Calder, F. D. Johnstone and J. D. Walker ON BEHALF OF THE SCOTTISH MULTICENTRE STUDY OF DIABETES IN PREGNANCY

British Heart Foundation Cardiovascular Research Centre (R.S.L.), University of Glasgow, Western Infirmary, Glasgow G11 6NT, United Kingdom; Diabetes Research Institute and 3rd Medical Department (A.-G.Z.), Krankenhaus Munchen-Schwabing, Munich, Germany; University Department of Obstetrics and Gynaecology (B.A.H., A.A.C., F.D.J.), Centre for Reproductive Biology, University of Edinburgh, Edinburgh, United Kingdom; and Diabetic Department (J.D.W.), St John’s Hospital at Howden, West Lothian National Health Service Trust Livingston, West Lothian EH54 6PP, United Kingdom

Address all correspondence and requests for reprints to: Robert Lindsay, British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Western Infirmary, 44 Church Street, Glasgow G11 6NT, United Kingdom. E-mail: rsl3c{at}clinmed.gla.ac.uk.

During pregnancy, maternal type 1 diabetes-associated autoantibodies may cross the placenta. It is proposed that insulin antibodies (IA) allow transfer of insulin across the placenta, contributing to fetal hyperinsulinemia and macrosomia.

We assessed the prevalence of IA, the tyrosine phosphatase IA-2, and glutamic acid decarboxylase (GADA) in cord blood from offspring of mothers with type 1 diabetes (ODM, n = 138) and control mothers (control, n = 47) and further assessed cross-sectional relationships of antibody titers to birth weight and fetal insulin.

In ODM, antibodies were frequently present in cord blood; 124 ODM (95%) were positive for IA, 82 (59%) were positive for GADA antibodies, and 61 (44%) were positive for IA-2 antibodies. In controls, GADA and IA-2 antibodies were absent, whereas seven controls (15%) were positive for IA at low titers (P < 0.0001 ODM vs. controls for all).

ODM with IA (IA positive) or without IA (IA negative) had similar birth weights (mean ± SD: IA positive, 3.8 ± 0.7 kg; IA negative, 4.0 ± 0.6 kg; P = 0.31) and cord insulin concentrations (IA positive: median, 112 pmol/liter; interquartile range, 62–219 pmol/liter; IA negative: median, 114 pmol/liter; interquartile range, 59–194 pmol/liter; P = 0.96). Similarly, the presence of GADA and/or IA-2 autoantibodies (n = 103) was not associated with differences in birth weight or insulin concentrations. Antibody titers were not associated with birth weight or insulin as continuous variables in either controls or ODM.

Islet autoantibodies and IA are a common finding in cord blood of ODM, but we found no evidence that they influence offspring insulin concentrations or weight at birth.

This work was supported by Project Grant K/MRS/50/C2726 from the Chief Scientist Office of the Scottish Office.

Abbreviations: GADA, Glutamic acid decarboxylase; IA, insulin antibodies; IA-2A, antibodies to the tyrosine phosphatase IA-2; IQR, interquartile range; LMP, last menstrual period; ODM, offspring of mothers with type 1 diabetes.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
S. E. Fineberg, T. T. Kawabata, D. Finco-Kent, R. J. Fountaine, G. L. Finch, and A. S. Krasner
Immunological Responses to Exogenous Insulin
Endocr. Rev., October 1, 2007; 28(6): 625 - 652.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. de Leiva, D. Mauricio, and R. Corcoy
Diabetes-Related Autoantibodies and Gestational Diabetes
Diabetes Care, July 1, 2007; 30(Supplement_2): S127 - S133.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society